LB Pharmaceuticals Inc Common Stock LBRX Income Statement
| FY'25 | ||
|---|---|---|
| $16.74M— | ||
| $13.66M— | ||
| $30.4M— | ||
| $5.21M— | ||
| -$25.2M— | ||
| $1K— | ||
| -$25.2M+60.1% | ||
| —— | ||
| -$24.88M— | ||
| -$25.2M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is LB Pharmaceuticals Inc Common Stock profitable?
- LB Pharmaceuticals Inc Common Stock is not currently profitable: it reported a net loss of $39.0M over the trailing twelve months.
- What is LB Pharmaceuticals Inc Common Stock's earnings per share?
- LB Pharmaceuticals Inc Common Stock's diluted EPS over the trailing twelve months is $-30.07.
- Where does LB Pharmaceuticals Inc Common Stock's income statement data come from?
- Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.